Indian public company incorporated
External corporate data identifies the issuer and its CIN. Confirm current particulars with the MCA before relying on the record.
The Company Check — corporate profileAgriculture, intelligence and execution — across borders. · Agriculture & food processing
The potential attraction is the group's combination of agri-input supply, farmer advisory and cross-border distribution. The key investment question is how much of that operating activity, and its earnings, belongs to this particular legal company.
Growfast Direct · 4 Nov 2026
Source-reported indication, not a live quote or executable offer.Private-market indications may change without daily trades. Ask for the latest dated reference and its source.
There is no continuous public exchange order book for these shares. Dealer and provider indications may differ by date, terms and methodology.
Compare sourcesInvade Agro Global describes an integrated agriculture platform spanning regulated agri-input distribution, agronomy advisory, field intelligence and supply-chain execution. This creates an interesting business to research where agriculture, technology and regional market access converge.
The research story is the connection between inputs, farmer-level intelligence and distribution. If the network and operating economics are supported by audited company-level evidence, they could provide a differentiated foundation for understanding business quality and scale.
EQUYRA editorial research · Strengths described above are business opportunities, not verified returns, price targets or investment recommendations. Group-level statements must not be represented as the financial results of the named Indian legal entity.
EQUYRA checked publicly displayed price indications on 4 November 2026. Dates differ by provider; these are not exchange-traded prices, executable orders or a licensed live feed.
These are editorial references to selected independently viewed pages, not an imported or redistributable provider dataset. The lowest and highest numbers are from different sources or times — they are not a bid/ask spread. Follow each link for the provider's original context and current terms.
Do not calculate or publish a definitive market cap, P/E, P/B or shareholder concentration from these third-party figures until the issuer, RTA and MCA certify the current share count, corporate actions and audited accounts.
| Paid-up capital reported | Source | Source record date |
|---|---|---|
| ₹73.21 CrReported paid-up capital | Tofler | Page updated 23 Oct 2026; figure's underlying record date unclear |
| ₹96.96 CrReported paid-up capital | The Company Check | Profile updated 18 Jul 2026 |
| ₹300.20 CrImplied by third-party reported share count of 30,01,96,244 at ₹10 face value; not primary verified | Unlisted Shares India | No reliable record date provided |
Identity is independently corroborated, including by a BSE-filed acquirer disclosure. Share status is repeatedly reported as unlisted. Indicative prices exist, but the price observations differ in date and origin. Outstanding shares and paid-up capital conflict materially across sources; a definitive market cap, EPS or price-to-book ratio cannot be published until reconciled to issuer/RTA and MCA primary records.
A third-party seller lists FY2024-25 financial figures, but no authenticated audited company statements were obtained in this review. Reported earnings, margins and market capitalisation must not be treated as independently verified.
Editorial research checked on 4 November 2026. No connected pricing API, authenticated financial filing, regulator approval or execution service is implied.
Explore historical published indications with dates, source information and clear evidence limits—not an invented trading curve.
These are individual, irregular external references, not verified trades, daily prices, returns or a reliable momentum signal. Different providers may use different methodologies. Missing dates are intentionally left blank.
Available history: 14 Nov 2025 to 4 Nov 2026. Only sparse 2025–2026 dated indications and provider-reported 52-week extrema were located. There is no validated continuous 2024–2026 trading history.| Observation | Price | Reference | Source |
|---|---|---|---|
| 4 Nov 2026 | ₹73.26 | Growfast DirectIndicative · Provider-dated public indication; no verified execution or settlement. | Source |
| 21 Oct 2026 | ₹82.00 | Safal CapitalIndicative · Provider-dated indicative level; not a committed bid or transaction. | Source |
| 12 Sept 2026 | ₹71.75 | PlanifyIndicative · Provider-dated indicative research reference; methodology not independently checked. | Source |
| 11 Sept 2026 | ₹82.00 | UnlistedZoneIndicative · Provider-dated indicative level; source as-of 11 September 2026. | Source |
| 3 Jun 2026 | ₹78.00 | WWIPLProvider high/low · Provider-reported 52-week high, with a claimed date; not an authenticated transaction. | Source |
| 14 Nov 2025 | ₹54.00 | WWIPLProvider high/low · Provider-reported 52-week low, with a claimed date; not an authenticated transaction. | Source |
Publicly traceable corporate records and research observations, separated from promotional milestones.
External corporate data identifies the issuer and its CIN. Confirm current particulars with the MCA before relying on the record.
The Company Check — corporate profileA BSE-filed document identifies Invade Agro as a proposed acquirer. Any cited offer price concerns the target company's securities—not Invade Agro shares.
BSE-filed public disclosureAn additional BSE-filed open-offer document provides a further source trail for researching corporate activity. It is not a share valuation for this issuer.
BSE-filed disclosureA third-party provider published a price indication. It has not been authenticated as an executed transaction.
Growfast Direct public referenceEntries are dated references, not a complete event register. Each source has its own reliability and reporting period. No IPO timeline is inferred.
Potential business drivers are hypotheses for research, not financial forecasts. Each requires evidence.
Seeds, crop nutrition and other recurring farm inputs can create repeat buying cycles if customer retention and margins are strong.
Evidence to seek: Confirm product-level revenue, gross margins and repeat-order rates.The group reports a broad branch and FPO network. If this company's economic interest and operating efficiency are documented, distribution could be a meaningful differentiator.
Evidence to seek: Verify entity ownership, branches, distribution contracts and operating contribution.Soil and crop advisory may deepen customer engagement and improve procurement planning, provided adoption and monetisation are real.
Evidence to seek: Review field deployment metrics, recurring revenue and audited segment disclosures.A global operating footprint does not establish that the Indian issuer owns those revenues, assets or contracts.
Check: Obtain consolidated-group structure and related-party transactions.Agricultural distribution can face credit, seasonality, currency and product-licensing risks.
Check: Review receivables ageing, inventory, FX sensitivity and permit status.Dealer indications can differ widely and there may be no buyer when an investor wants to sell.
Check: Confirm share rights, transfer conditions, transaction costs and liquidity.What is the verified financial contribution of the Indian company, separate from the group's global operations?
Real financials will populate this dashboard only after we can verify signed, period-matched statements for the exact issuer.
Authenticated standalone and consolidated accounts for these legal issuers are not yet available in this dossier. Conflicting third-party capital figures and missing signed statements prevent reliable EPS, P/E, P/B, market capitalisation and issuer-level profit analysis. Missing does not mean zero.
Inspect the capital evidence reviewWhen reliable statements, current share capital and a comparable peer set are available, EQUYRA can show operating growth, earnings quality, cash generation and transparent bull/base/bear sensitivity—not an unsupported price target.
Compare operating exposure and current evidence, not unsupported stock rankings or price-only judgements.
Agriculture, intelligence and execution — across borders.
Turning agricultural sourcing into essential food value.
Share prices of different issuers are not comparable measures of value without shares outstanding, audited financials and share rights. The observations above are dated, non-executable references.
Explore how a hypothetical entry price, future exit and costs change the mathematical result. These scenarios do not predict what this company will earn or trade at.
Starting input uses the Growfast Direct indication dated 2026-11-04, editable by you. It is not a guaranteed purchase price or an available offer.
Outputs assume all shares can be sold at your chosen exit price after the holding period. That may not be possible in an illiquid market. Taxes, transfer restrictions, deal availability, share dilution and time-to-exit uncertainty are not modelled. The annualised figure is mathematical, not an expected return.
Open the wider educational valuation labImportant constraints and missing information, shown plainly rather than hidden in the technical appendix.
A published indicative price does not identify a committed buyer or a confirmed exit route.
Current RTA/depository rights, lock-ins, applicable restrictions and transfer procedure are not confirmed.
No listing event or date should be inferred from inclusion in this research universe.
Published group descriptions and third-party extracts cannot substitute for signed, issuer-specific accounts.
EQUYRA gives these two Invade ecosystem companies prominent editorial placement. Any ownership, management, commercial or other relationship between EQUYRA's operator and the featured issuers should be disclosed explicitly and kept separate from investment research. Editorial prominence is not a recommendation or verified security approval.
Save this dossier in your current browser. When you return, EQUYRA can flag new research-source dates compared with your saved snapshot.
This is browser-local tracking, not an investor account, push notification, email alert or live monitoring service. Clearing browser data removes your watchlist. Automated alerts require authenticated accounts, a backend and an authorised delivery channel.
Automatically organised from the dossier's attributed records: what can be observed, where sources disagree, and what an investor still needs to know.
Found 4 dated indications from 4 providers. 2 of those were more than 30 days old at the research review date. Prices cannot be interpreted as executed trades or calculated daily returns.
A permissioned, source-dated provider quotation with quote type, quantity and settlement terms.
External registries report 3 differing paid-up capital or implied share-count values. Their record dates and definitions differ, so no single current share count can responsibly be assumed.
Current MCA filings, reconciled statement of capital, RTA/depository confirmation and corporate-action history.
A third-party seller lists FY2024-25 financial figures, but no authenticated audited company statements were obtained in this review. Reported earnings, margins and market capitalisation must not be treated as independently verified.
Audited signed standalone and consolidated accounts, notes, reporting periods and auditor opinion.
The wider group describes operating networks and market opportunities. Those claims do not establish which revenues, facilities or contracts belong to Invade Agro Limited.
Entity ownership chart, group consolidation perimeter, related-party disclosures and issuer-level operating KPIs.
These findings are deterministic comparisons of editorially recorded source data, not independent authentication, an AI-generated forecast or an investment recommendation. Different record dates can explain part of a capital discrepancy; the correct figure requires primary documents.
Automated evidence collection, research synthesis, notification infrastructure and operational safeguards. Every active capability identifies its actual source and status.
Missing licences and credentials remain disabled. Unsupported quotes, capital records and predictions are quarantined or omitted. There is no automated trade execution or personalised securities recommendation.
The latest automated accessibility observations for this company's research sources.
Monitoring is not verification. A reachable or changed webpage does not authenticate the company, update an indicative price, certify audited figures or establish that shares can be traded. When new or conflicting information is found, EQUYRA must retain the last attributed record until the evidence is validated.
Explore reviewed research questions about Invade Agro Limited. Answers are built from this site's labelled references, not invented AI predictions.
Invade Agro Global describes an integrated agriculture platform spanning regulated agri-input distribution, agronomy advisory, field intelligence and supply-chain execution. This creates an interesting business to research where agriculture, technology and regional market access converge.
Research answers use reviewed company evidence and citations. An AI model is used only if its private access is configured; otherwise the system returns deterministic analysis. Nothing here is personalised investment advice.
Use verified documents or your own assumptions. These calculators do not infer actual issuer valuation or liquidity.
Calculate growth, margins, cash conversion, leverage and working-capital ratios from documents you provide.
Open tool Share dilution modelTest how new primary shares and your participation change percentage ownership and economic exposure.
Open tool Private exit plannerModel proceeds, transaction-cost drag and the uncertainty of selling only part of a holding.
Open tool Valuation sensitivityExplore a transparent, user-assumption DCF model without inventing issuer financials.
Open tool Real issuer comparisonCompare source dates and verified-data gaps for Invade Agro and Invade Mill.
Open tool My research watchlistRevisit candidate shortlists and company research you've saved locally.
Open toolEducational and research tools. Inputs are supplied by users or come from clearly dated editorial source registers. None creates an executable order or an investment recommendation.
Each step needs an attributable record and human review before EQUYRA can publish a sourced analysis.
Confirm legal name, CIN, jurisdiction, company type and current status in an official register.
Verify ISIN, share class, demat eligibility, transfer restrictions, lock-ins and corporate actions.
Obtain permitted audited statements, reporting period, revenue, earnings, debt, cash flow and auditor notes.
Secure permissioned dated dealer indications and distinguish bids, asks, transactions and scenarios.
Validate shares outstanding, dilution, net debt, peer set and historical financial inputs before calculating value.
Assess business concentration, control, shareholder rights, audit quality, regulatory exposure and available exit routes.
These official registers and providers supply independent research starting points. No licensed market data feed or verified tradable share price is implied.
Financial reporting is attached only to a verified legal entity and an approved original document. Estimates and group claims never replace missing accounts.
Revenue, profitability, EPS, ROE, ROCE, debt, audited cash flows, P/E and EV/EBITDA cannot be confirmed for this legal issuer. An empty field does not imply a zero balance or poor performance.
Analyse your own approved documentsRatios must use permissioned public filings, common reporting periods and clearly stated enterprise or equity valuation assumptions.
Unlisted nominal share prices cannot be compared with listed market prices. This section will populate only from rights-cleared, period-matched evidence.
Only dated, source-attributed IPO filings are displayed. An issuer's inclusion in research does not imply an IPO is planned.
No dated DRHP, regulatory acceptance or confirmed listing timetable has been connected to this legal issuer. EQUYRA does not assign an IPO probability.